Methodist Hospitals Inc
Acute Care Hospitals · Voluntary non-profit - Private
600 Grant St
Gary, IN 46402
- Emergency services
- Medicare overall rating: 1 of 5 stars
At a glance
- Clinicians who list this hospital
- 467
- Physicians (MD and DO)
- 330
- Residents and fellows in training (full-time equivalents, fiscal year 2024)
- 3
- Medical groups
- 15+
Quality and patient experience
- Medicare overall rating (of 5)
- 1
- Patient survey rating (of 5)
- 2
- Patients who would definitely recommend it (national average 71%)
- 54%
Compared with the national rate
| Measures | Better | Same | Worse |
|---|---|---|---|
| Deaths after treatment | 0 | 7 | 0 |
| Safety of care (infections, complications) | 2 | 4 | 1 |
| Readmissions and return visits | 0 | 6 | 3 |
Number of Medicare quality measures where this hospital’s rate is statistically better than, the same as (no different from), or worse than the national rate.
What patients said
- Doctors communicated well 2 of 5 stars
- Nurses communicated well 1 of 5 stars
- Explained medicines 2 of 5 stars
- Discharge information 2 of 5 stars
- Clean 2 of 5 stars
- Quiet at night 3 of 5 stars
From 1,014 patient surveys (HCAHPS), period ending 09/30/2025.
Medicare “birthing-friendly” hospital: takes part in a maternity care quality program and follows recommended safety practices.
Source: CMS Care Compare (Hospital General Information; Patient survey HCAHPS). Ratings describe the hospital overall, not individual doctors.
Physicians by specialty
- Family Medicine 45
- Internal Medicine 37
- Emergency Medicine 30
- Radiology 21
- OB-GYN (Obstetrics & Gynecology) 16
- Cardiology 14
- Nephrology (Kidney) 13
- Pulmonology 11
- Anesthesiology 10
- General Surgery 9
- Neurology 9
- Infectious Disease 9
- Gastroenterology 9
- Hospitalist 8
- Hematology & Oncology 7
- Orthopedic Surgery 7
- Urology 6
- Interventional Radiology 5
- Endocrinology & Diabetes 5
- Pathology 5
- Psychiatry 5
- Neurosurgery 4
- Radiation Oncology 4
- Neuroradiology 3
- Cardiac Electrophysiology 3
- Interventional Cardiology 3
- Pain Medicine 3
- Ophthalmology 3
- Cardiothoracic Surgery 2
- Sports Medicine 2
- Plastic Surgery 2
- Hand Surgery 2
- ENT (Otolaryngology) 2
- Spine Surgery 2
- Child Neurology 2
- Medical Oncology 2
- Geriatric Medicine 2
- Allergy & Immunology 1
- Trauma Surgery 1
- Physical Medicine & Rehabilitation (PM&R) 1
- Heart Failure & Transplant Cardiology 1
- General Practice 1
- Sleep Medicine 1
- Rheumatology 1
- Retina Specialist 1
Other clinicians
Medical groups whose clinicians work here
- The Methodist Hospitals Inc 110
- Redreef Anesthesia Associates Chartered Indiana LLC 33
- Cep America LLC 28
- Sound Physicians of Indiana LLC 27
- Community Care Network Inc 27
- Chesterton Physical Therapy Inc 24
- Anesthesia Dynamics LLC 18
- N W Indiana Radiology Services, PC 15
- Advanced Imaging Center LLC 12
- Dalal Medical Corporation 9
- Infectious Disease Specialists PC 9
- Methodist Hospitals Cardiographics, LLC 9
- Uro Surgery Associates LLC 8
- Oak Street Health Physicians Group PC 7
- Powers Health Diagnostic Group LLC 6
Number of each group’s clinicians who list this hospital.
Industry-funded research here
Drug and device companies reported $112,248 in research payments to this hospital in 2025 for 5 studies.
- Ultrasound-facilitated, Catheter-directed, Thrombolysis in Intermediate-high Risk Pulmonary Embolism
Boston Scientific Corporation · $51,709 · Active, not recruiting - Efficacy and Safety Study of Frexalimab (SAR441344) in Adults With Nonrelapsing Secondary Progressive Multiple Sclerosis
Genzyme Corporation · $29,666 · Active, not recruiting - A Randomized, Double-blind, Double-dummy, Parallel-group Study, Comparing the Efficacy and Safety of Remibrutinib Versus Teriflunomide in Participants With Relapsing Multiple Sclerosis, Followed by Extended Treatment …
Novartis Pharmaceuticals Corporation · $15,299 - Efficacy and Safety Studies of Frexalimab (SAR441344) in Adults With Relapsing Forms of Multiple Sclerosis
Genzyme Corporation · $14,495 · Active, not recruiting - Phase 2, proof-of-concept, randomized, double-blinded, placebo-controlled, multicenter study to assess efficacy and safety of reparixin as add-on therapy to standard of care in adult patients with Acute Respiratory …
Dompe Farmaceutici S.p.a. · $1,079
From CMS Open Payments research payments to this hospital as a teaching hospital. Payments to affiliated universities or research foundations are reported under those names. All industry-funded trials →
Other hospitals in the same county
Sources: CMS Hospital General Information and Doctors and Clinicians Facility Affiliation (Care Compare), CMS certification number 150002. Counts are clinicians who list this hospital with Medicare; they include part-time and visiting clinicians and aren’t staff totals. Residents and beds are from the hospital’s Medicare cost report. Ratings are Medicare’s, not ours.